Therapeutic Group: Ophthalmic Presentation Lomequin 0.3% eye drops: Each ml contains Lomefloxacin Hydrochloride INN equivalent to Lomefloxacin 3 mg. Description Lomefloxacin is a synthetic, broad-spectrum, second generation fluoroquinolone antibacterial agent. It works by the inhibition of bacterial DNA gyrase enzymes required for DNA replication, transcription, repair and recombination. Indications Lomequin eye drops is indicated for […]
Therapeutic Group: Drugs of Nervous System Presentation Lithin SR Tablet: Each Sustained Release tablet contains Lithium Carbonate BP 400 mg. Description Preclinical studies have shown that lithium alters sodium transport in nerve and muscle cells and effects a shift toward intraneuronal metabolism of catecholamines, but the specific biochemical mechanism of lithium action in mania is […]
Therapeutic Group: Anti Bacterial Presentation Linzolid 400 Tablet: Each film-coated tablet contains Linezolid INN 400 mg. Linzolid 600 Tablet: Each film-coated tablet contains Linezolid INN 600 mg. Linzolid Powder for Suspension: After reconstitution, according to direction, each 5 ml suspension contains Linezolid INN 100 mg. Linzolid 600 IV Infusion: Each 300 ml solution contains Linezolid […]
Therapeutic Group: Anti Bacterial Presentation Each gm powder contains Lincomycin Hydrochloride BP equivalent to Lincomycin 44 mg. Description Lincomycin is a lincosamide antibiotic with activity against Gram-positive and cell wall-less bacteria including pathogenic species of Streptococcus, Staphylococcus, and Mycoplasma. Lincomycin is used to treat severe bacterial infections. Indications Necrotic enteritis, Non Specific Enteritis, Chronic Respiratory […]
Therapeutic Group: Anti Diabetic Presentation Linatab M 2.5/1000 ER: Each Extended Release tablet contains Linagliptin INN 2.5 mg and Metformin HCl BP 1000 mg. Linatab M 5/1000 ER: Each Extended Release tablet contains Linagliptin INN 5 mg and Metformin HCl BP 1000 mg. Description LINATAB M ER is a combination of 2 oral antihyperglycemic drugs […]
Therapeutic Group: Anti Diabetic Presentation Linatab M 2.5/500: Each tablet contains Linagliptin 2.5 mg + Metformin HCl BP 500 mg. Linatab M 2.5/850: Each tablet contains Linagliptin 2.5 mg + Metformin HCl BP 850 mg. Linatab M 2.5/1000: Each tablet contains Linagliptin 2.5 mg + Metformin HCl BP 1000 mg Description LINATAB M is a […]
Therapeutic Group: Anti Diabetic Presentation Linatab E 5/10: Each tablet contains Linagliptin INN 5 mg and Empagliflozin INN 10 mg. Linatab E 5/25: Each tablet contains Linagliptin INN 5 mg and Empagliflozin INN 25 mg. Description Linatab E is a combination of two oral antihyperglycemic drugs with complimentary mechanism of action to improve glycemic control […]
Therapeutic Group: Anti Diabetic Presentation Linatab : Each tablet contains Linagliptin INN 5 mg. Description Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which exerts its action by slowing the inactivation of incretin hormones. Incretin hormones, including glucagon-like peptide-1(GLP-1) and glucose-dependent Insulinotropic polypeptide (GIP), are released by the intestine throughout the day and levels are increased […]
Therapeutic Group: Gastro Intestinal Disorders Presentation Anacaine HC Cream: Each gram cream contains Lidocaine Hydrochloride BP 30 mg and Hydrocortisone Acetate BP 5 mg. Description Lidocaine inhibits the ionic fluxes required for initiation and conduction of impulses, thereby effecting local anesthetic action. Hydrocortisone acetate provides relief from inflammatory and pruritic manifestations. Indications Anacaine Cream is […]
Therapeutic Group: Respiratory Presentation Purisal 0.31 mg: Each 3 ml ampoule contains Levosalbutamol Hydrochloride INN equivalent to Levosalbutamol 0.31 mg. Purisal 0.63 mg: Each 3 ml ampoule contains Levosalbutamol Hydrochloride INN equivalent to Levosalbutamol 0.63 mg. Purisal 1.25 mg: Each 3 ml ampoule contains Levosalbutamol Hydrochloride INN equivalent to Levosalbutamol 1.25 mg. Description Levosalbutamol Nebuliser […]